AKTX
Akari Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AKTX fundamentals
Akari Therapeutics (AKTX) released its earnings on Aug 13, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was 0 (YoY 0.00%), beat estimates.
Revenue / YoY
--
0.00%
EPS / YoY
0
0.00%
Report date
Aug 13, 2025
Earnings Call
11:00 AM on Aug 18, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Akari Therapeutics (AKTX) key financial stats and ratios, covering profitability, financial health, and leverage.
Akari Therapeutics (AKTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Akari Therapeutics (AKTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Akari Therapeutics (AKTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Akari Therapeutics (AKTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Akari Therapeutics (AKTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What does Akari Therapeutics do and what are its main business segments?Did Akari Therapeutics beat or miss consensus estimates last quarter?What is Akari Therapeutics's latest dividend and current dividend yield?What is the market's earnings forecast for Akari Therapeutics next quarter?What is the revenue and EPS growth rate for Akari Therapeutics year over year?What is Akari Therapeutics's gross profit margin?What were the key takeaways from Akari Therapeutics's earnings call?What were the key takeaways from Akari Therapeutics’s earnings call?
